- Home
- SDOT vs ADXN Comparison
SDOT vs ADXN Comparison
Compare SDOT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- ADXN
- Stock Information
- Founded
- SDOT 2014
- ADXN 2002
- Country
- SDOT United States
- ADXN Switzerland
- Employees
- SDOT N/A
- ADXN N/A
- Industry
- SDOT Restaurants
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- ADXN Health Care
- Exchange
- SDOT Nasdaq
- ADXN Nasdaq
- Market Cap
- SDOT 8.0M
- ADXN 8.1M
- IPO Year
- SDOT 2020
- ADXN N/A
- Fundamental
- Price
- SDOT $1.19
- ADXN $10.23
- Analyst Decision
- SDOT
- ADXN Strong Buy
- Analyst Count
- SDOT 0
- ADXN 1
- Target Price
- SDOT N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SDOT 75.9K
- ADXN 1.4K
- Earning Date
- SDOT 05-14-2025
- ADXN 06-17-2025
- Dividend Yield
- SDOT N/A
- ADXN N/A
- EPS Growth
- SDOT N/A
- ADXN N/A
- EPS
- SDOT 1.07
- ADXN 0.08
- Revenue
- SDOT $726,598,000.00
- ADXN $452,495.00
- Revenue This Year
- SDOT $12.76
- ADXN $86.57
- Revenue Next Year
- SDOT $5.54
- ADXN N/A
- P/E Ratio
- SDOT $1.10
- ADXN $0.88
- Revenue Growth
- SDOT 18.91
- ADXN N/A
- 52 Week Low
- SDOT $1.12
- ADXN $6.51
- 52 Week High
- SDOT $7.00
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- SDOT 33.39
- ADXN 73.57
- Support Level
- SDOT $1.16
- ADXN $8.08
- Resistance Level
- SDOT $1.25
- ADXN $8.20
- Average True Range (ATR)
- SDOT 0.09
- ADXN 0.23
- MACD
- SDOT 0.03
- ADXN 0.11
- Stochastic Oscillator
- SDOT 24.14
- ADXN 71.04
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.